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Introduction The variant rs738409 in PNPLA3 is associated with an increased risk of 
developing both significant alcohol-related liver disease and, in this context, adverse 
clinical outcomes. The aim of this study was to determine whether, in severe alcoholic 
hepatitis, carriage of rs738409:G is associated with impaired recovery of liver function.  
 
Method Cases with severe alcoholic hepatitis were recruited prospectively through the 
Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) trial. Biochemical and 
haematological data were collected at baseline and the day 90 visit. Self-reported alcohol 
consumption was recorded at day 90 and categorised as abstinent or drinking. The rates 
of change in serum bilirubin and albumin concentrations and the international normalised 
ratio (INR) were examined in relation to rs738490 genotype and drinking behaviour.  
 
Results Paired information on rs738409 genotype and laboratory variables was available 
in 377 cases; information on drinking behaviour was available in 365 (97%). Carriage of 
rs738409:G was associated with a slower decline in median serum bilirubin concentration 
(CC: 0.0084 mmol/l/day [IQR 0.0066–0.010]; CG: 0.0080 [0.0053–0.0098]; GG 0.0072 
[0.0045–0.0092], p < 0.001) and a slower recovery of serum albumin concentrations and 
(CC: 0.0027 g/l/day [0.0009–0.006]; CG: 0.0025 [0.0005– 0.0032]; GG 0.0017 [0.0004–
0.0035], p=0.04), but did not appear to influence recovery of the INR (p=0.90 (Figure 1). 
Resumption of drinking by day 90 significantly influenced the recovery rates of all three 
laboratory variables viz. serum bilirubin: (abstinent 0.0088 [0.0069–0.01] vs drinking 
0.0067 [0.0026–0.009], serum albumin (0.0027 [0.0057– 0.001] vs 0.0018 [0.0042–
0.0003], p=0.007); and INR (0.0022 [0.0012–0.0034] vs 0.0013 [ 0.0005–0.0027], p 
<0.001). The observed effect of rs738409 genotype on the rates of recovery of laboratory 
variables differed in groups defined by drinking behaviour; recovery rates were slower in 
abstinent individuals who carried rs738409:G but rates were not further influenced by 
genotype in those who continued to drink 
 
Conclusion In people who survive an acute episode of severe alcoholic hepatitis carriage 
of rs738409:G is associated with slower rates of recovery in serum bilirubin and albumin. 
Early resumption of drinking also significantly slows recovery of these and laboratory 
variables. The greatest influence of rs738409:G was in relation to recovery rates in 
abstinent people.  
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